Evolv Technologies director trades 80,745 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Michael Ellenbogen, a director of Evolv Technologies Holdings, Inc., exercised stock options for 80,745 shares of Class A Common Stock at $0.24 per share and on the same date sold 80,745 shares at a weighted-average price of $5.94 under a Rule 10b5-1 trading plan. Following these transactions, he holds 2,083,961 shares directly, 151,135 shares indirectly through the Family Horizon Trust, and 897,014 stock options expiring on September 13, 2027.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F3 | 80,745 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 80,745 | $0.24 | $19K |
| Sale | Class A Common Stock F1, F2 | 80,745 | $5.94 | $480K |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (3)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3. The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Stock Option (Right to Buy) financial
underlying security financial
Family Horizon Trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Michael Ellenbogen report for EVLV on July 15, 2026?
What options did Michael Ellenbogen exercise in this EVLV Form 4 filing?
How many EVLV stock options remain outstanding for Michael Ellenbogen after this exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.